• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

常染色体显性多囊肾病1型(ADPKD1)患者肾和肝上皮囊肿细胞中的杂合性缺失。

Loss of heterozygosity in renal and hepatic epithelial cystic cells from ADPKD1 patients.

作者信息

Badenas C, Torra R, Pérez-Oller L, Mallolas J, Talbot-Wright R, Torregrosa V, Darnell A

机构信息

Department of Nephrology, Hospital Clinic, Institut d'Investigacions BiomMèdiques August Pi i Sunyer, University of Barcelona, Spain.

出版信息

Eur J Hum Genet. 2000 Jul;8(7):487-92. doi: 10.1038/sj.ejhg.5200484.

DOI:10.1038/sj.ejhg.5200484
PMID:10909847
Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is one of the commonest genetic diseases in man, affecting 1:1000 individuals in the Caucasian population. It is caused by mutations in the PKD1 or PKD2 genes. Recently, controversial data regarding the mutational mechanism underlying cyst initiation have been reported: genetic analyses have shown that second somatic mutations may lead to cyst formation (detected as microsatellite loss of heterozygosity, LOH, and point mutations), but immunohistochemical studies show strong immunoreactivity for polycystin in some cysts. In order to further characterise this matter we have analysed 211 cysts from seven different patients for LOH, we have detected a 13.3% LOH for PKD1. This loss was specific to PKD1 as no LOH was detected when other chromosomal regions were studied. Whenever linkage analysis has been possible, it has been proved that the lost allele corresponded to the wild-type. Our data supports previous results in the two-hit theory for ADPKD due to the large number of cysts studied. ADPKD would occur through a recessive cellular mechanism. The probability of cyst development would depend on the probability of mutation in the second allele. The different phenotypical expression of the same mutation reported in ADPKD could be due to the different tendency of inactivation in the second allele in each individual.

摘要

常染色体显性多囊肾病(ADPKD)是人类最常见的遗传病之一,在白种人群中发病率为1:1000。它由PKD1或PKD2基因突变引起。最近,关于囊肿起始的突变机制有一些有争议的数据报道:基因分析表明,第二次体细胞突变可能导致囊肿形成(表现为微卫星杂合性缺失,即LOH,以及点突变),但免疫组化研究显示,在一些囊肿中多囊蛋白有很强的免疫反应性。为了进一步明确这一问题,我们分析了来自7名不同患者的211个囊肿的杂合性缺失情况,检测到PKD1的杂合性缺失率为13.3%。这种缺失是PKD1特有的,因为研究其他染色体区域时未检测到杂合性缺失。只要进行了连锁分析,就已证明丢失的等位基因对应野生型。由于研究的囊肿数量众多,我们的数据支持了先前关于ADPKD的二次打击理论的结果。ADPKD可能通过隐性细胞机制发生。囊肿发生的概率将取决于第二个等位基因突变的概率。ADPKD中报道的相同突变的不同表型表达可能是由于每个个体中第二个等位基因失活的不同倾向。

相似文献

1
Loss of heterozygosity in renal and hepatic epithelial cystic cells from ADPKD1 patients.常染色体显性多囊肾病1型(ADPKD1)患者肾和肝上皮囊肿细胞中的杂合性缺失。
Eur J Hum Genet. 2000 Jul;8(7):487-92. doi: 10.1038/sj.ejhg.5200484.
2
[Heterozygosity loss and somatic mutations in type I and II dominant autosomal renal polycystic kidney disease: evidence of a recessive mechanism at a cell level in cystogenesis].[I型和II型常染色体显性遗传性多囊肾病中的杂合性缺失和体细胞突变:囊肿形成中细胞水平隐性机制的证据]
Nefrologia. 2000 Mar-Apr;20(2):130-8.
3
Mutations of PKD1 in ADPKD2 cysts suggest a pathogenic effect of trans-heterozygous mutations.常染色体显性多囊肾病2型囊肿中多囊蛋白1的突变提示反式杂合突变的致病作用。
Nat Genet. 2000 Jun;25(2):143-4. doi: 10.1038/75981.
4
PKD1 and PKD2 mutations in Slovenian families with autosomal dominant polycystic kidney disease.斯洛文尼亚常染色体显性多囊肾病家族中的PKD1和PKD2突变
BMC Med Genet. 2006 Jan 23;7:6. doi: 10.1186/1471-2350-7-6.
5
Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2).常染色体显性多囊肾病(ADPKD,MIM 173900,PKD1和PKD2基因,其蛋白质产物分别称为多囊蛋白-1和多囊蛋白-2)
Eur J Hum Genet. 2004 May;12(5):347-54. doi: 10.1038/sj.ejhg.5201162.
6
Molecular genetics and mechanism of autosomal dominant polycystic kidney disease.常染色体显性多囊肾病的分子遗传学与发病机制
Mol Genet Metab. 2000 Jan;69(1):1-15. doi: 10.1006/mgme.1999.2943.
7
A loss-of-function model for cystogenesis in human autosomal dominant polycystic kidney disease type 2.人类常染色体显性遗传性多囊肾病2型囊肿形成的功能丧失模型。
Am J Hum Genet. 1999 Aug;65(2):345-52. doi: 10.1086/302501.
8
Genes homologous to the autosomal dominant polycystic kidney disease genes (PKD1 and PKD2).与常染色体显性多囊肾病基因(PKD1和PKD2)同源的基因。
Eur J Hum Genet. 1999 Dec;7(8):860-72. doi: 10.1038/sj.ejhg.5200383.
9
[Mutational analysis of the PKD1 and PKD2 (type 1 and 2 dominant autosomal polycystic kidney) genes].[多囊肾病1型和2型(常染色体显性遗传多囊肾病)基因的突变分析]
Nefrologia. 2000 Jan-Feb;20(1):39-46.
10
Loss of the polycystic kidney disease (PKD1) region of chromosome 16p13 in renal cyst cells supports a loss-of-function model for cyst pathogenesis.肾囊肿细胞中16号染色体短臂1区3带的多囊肾病(PKD1)区域缺失支持了囊肿发病机制的功能丧失模型。
J Clin Invest. 1997 Jan 15;99(2):194-9. doi: 10.1172/JCI119147.

引用本文的文献

1
Role of Extracellular Vesicles in TSC Renal Cystogenesis.细胞外囊泡在结节性硬化症肾囊肿形成中的作用。
Int J Mol Sci. 2025 Mar 28;26(7):3154. doi: 10.3390/ijms26073154.
2
Triplex H-DNA structure: the long and winding road from the discovery to its role in human disease.三链体H-DNA结构:从发现到其在人类疾病中作用的漫长曲折之路。
NAR Mol Med. 2024 Dec 5;1(4):ugae024. doi: 10.1093/narmme/ugae024. eCollection 2024 Oct.
3
Somatic mutation in autosomal dominant polycystic kidney disease revealed by deep sequencing human kidney cysts.
通过对人肾囊肿进行深度测序揭示的常染色体显性多囊肾病中的体细胞突变
NPJ Genom Med. 2024 Dec 19;9(1):69. doi: 10.1038/s41525-024-00452-6.
4
Single Gene Mutations in or Alter Extracellular Vesicle Production and Trafficking.**或**中的单基因突变改变细胞外囊泡的产生和运输。 (注:原文中“in or ”表述不完整,推测可能是有遗漏信息,但按照要求完整翻译了现有内容)
Biology (Basel). 2022 May 6;11(5):709. doi: 10.3390/biology11050709.
5
Recent Discoveries in Epigenetic Modifications of Polycystic Kidney Disease.多囊肾病表观遗传修饰的最新发现。
Int J Mol Sci. 2021 Dec 11;22(24):13327. doi: 10.3390/ijms222413327.
6
Renal cystic disease in tuberous sclerosis complex.结节性硬化症相关的肾囊性病变。
Exp Biol Med (Maywood). 2021 Oct;246(19):2111-2117. doi: 10.1177/15353702211038378. Epub 2021 Sep 6.
7
Renal Manifestations of Tuberous Sclerosis Complex.结节性硬化症的肾脏表现
J Kidney Cancer VHL. 2020 Aug 27;7(3):5-19. doi: 10.15586/jkcvhl.2020.131. eCollection 2020.
8
Cystic renal-epithelial derived induced pluripotent stem cells from polycystic kidney disease patients.来自多囊肾病患者的囊性肾上皮源性诱导多能干细胞。
Stem Cells Transl Med. 2020 Apr;9(4):478-490. doi: 10.1002/sctm.18-0283. Epub 2020 Mar 12.
9
Tuberous Sclerosis Complex Axis Controls Renal Extracellular Vesicle Production and Protein Content.结节性硬化症复合轴控制肾脏细胞外囊泡的产生和蛋白含量。
Int J Mol Sci. 2020 Mar 3;21(5):1729. doi: 10.3390/ijms21051729.
10
Tuberous sclerosis complex exhibits a new renal cystogenic mechanism.结节性硬化症表现出一种新的肾囊肿发生机制。
Physiol Rep. 2019 Jan;7(2):e13983. doi: 10.14814/phy2.13983.